226 related articles for article (PubMed ID: 27830574)
21. New paradigms for treatment-resistant depression.
Zarate C; Duman RS; Liu G; Sartori S; Quiroz J; Murck H
Ann N Y Acad Sci; 2013 Jul; 1292():21-31. PubMed ID: 23876043
[TBL] [Abstract][Full Text] [Related]
22. Targeting glial physiology and glutamate cycling in the treatment of depression.
Valentine GW; Sanacora G
Biochem Pharmacol; 2009 Sep; 78(5):431-9. PubMed ID: 19376090
[TBL] [Abstract][Full Text] [Related]
23. 7T
Evans JW; Lally N; An L; Li N; Nugent AC; Banerjee D; Snider SL; Shen J; Roiser JP; Zarate CA
Neuropsychopharmacology; 2018 Aug; 43(9):1908-1914. PubMed ID: 29748628
[TBL] [Abstract][Full Text] [Related]
24. The association of glutamate level in pregenual anterior cingulate, anhedonia, and emotion-behavior decoupling in patients with major depressive disorder.
Wang KL; Liang K; Wang LJ; Shen JF; Zhu GH; Zhang SX; Wang XZ; Wang Y; Wang YY
Asian J Psychiatr; 2022 Dec; 78():103306. PubMed ID: 36308992
[TBL] [Abstract][Full Text] [Related]
25. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
Chaki S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):219-26. PubMed ID: 23012890
[TBL] [Abstract][Full Text] [Related]
26. Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.
Dogra S; Conn PJ
Neuropharmacology; 2021 Sep; 196():108687. PubMed ID: 34175327
[TBL] [Abstract][Full Text] [Related]
27. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole.
Banasr M; Chowdhury GM; Terwilliger R; Newton SS; Duman RS; Behar KL; Sanacora G
Mol Psychiatry; 2010 May; 15(5):501-11. PubMed ID: 18825147
[TBL] [Abstract][Full Text] [Related]
28. Inflammation and decreased functional connectivity in a widely-distributed network in depression: Centralized effects in the ventral medial prefrontal cortex.
Yin L; Xu X; Chen G; Mehta ND; Haroon E; Miller AH; Luo Y; Li Z; Felger JC
Brain Behav Immun; 2019 Aug; 80():657-666. PubMed ID: 31078690
[TBL] [Abstract][Full Text] [Related]
29. Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study.
Taylor MJ; Tiangga ER; Mhuircheartaigh RN; Cowen PJ
J Psychopharmacol; 2012 May; 26(5):733-7. PubMed ID: 21616979
[TBL] [Abstract][Full Text] [Related]
30. Neuro-metabolite profiles of rodent models of psychiatric dysfunctions characterised by MR spectroscopy.
Sekar S; Grandjean J; Garnell JF; Willems R; Duytschaever H; Seramani S; Su H; Ver Donck L; Bhakoo KK
Neuropharmacology; 2019 Mar; 146():109-116. PubMed ID: 30472272
[TBL] [Abstract][Full Text] [Related]
31. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
32. Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedonia.
John CS; Smith KL; Van't Veer A; Gompf HS; Carlezon WA; Cohen BM; Öngür D; Bechtholt-Gompf AJ
Neuropsychopharmacology; 2012 Oct; 37(11):2467-75. PubMed ID: 22739467
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.
Yüksel C; Öngür D
Biol Psychiatry; 2010 Nov; 68(9):785-94. PubMed ID: 20728076
[TBL] [Abstract][Full Text] [Related]
34. Cortical functional hyperconnectivity in a mouse model of depression and selective network effects of ketamine.
McGirr A; LeDue J; Chan AW; Xie Y; Murphy TH
Brain; 2017 Aug; 140(8):2210-2225. PubMed ID: 28899017
[TBL] [Abstract][Full Text] [Related]
35. The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.
Machado-Vieira R; Manji HK; Zarate CA
Neuroscientist; 2009 Oct; 15(5):525-39. PubMed ID: 19471044
[TBL] [Abstract][Full Text] [Related]
36. Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons.
Belloch FB; Cortés-Erice M; Herzog E; Zhang XM; Díaz-Perdigon T; Puerta E; Tordera RM
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110640. PubMed ID: 36209771
[TBL] [Abstract][Full Text] [Related]
37. A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria.
de Miranda AS; Brant F; Vieira LB; Rocha NP; Vieira ÉLM; Rezende GHS; de Oliveira Pimentel PM; Moraes MFD; Ribeiro FM; Ransohoff RM; Teixeira MM; Machado FS; Rachid MA; Teixeira AL
Mol Neurobiol; 2017 Nov; 54(9):7063-7082. PubMed ID: 27796746
[TBL] [Abstract][Full Text] [Related]
38. Dysfunctional glutamatergic and γ-aminobutyric acidergic activities in prefrontal cortex of mice in social defeat model of depression.
Veeraiah P; Noronha JM; Maitra S; Bagga P; Khandelwal N; Chakravarty S; Kumar A; Patel AB
Biol Psychiatry; 2014 Aug; 76(3):231-8. PubMed ID: 24239130
[TBL] [Abstract][Full Text] [Related]
39. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.
Walter M; Henning A; Grimm S; Schulte RF; Beck J; Dydak U; Schnepf B; Boeker H; Boesiger P; Northoff G
Arch Gen Psychiatry; 2009 May; 66(5):478-86. PubMed ID: 19414707
[TBL] [Abstract][Full Text] [Related]
40. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
Müller N; Schwarz MJ
Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
